MARATTO

article · Viruses

Whole-Transcriptome Analysis of Three Human Cell Lines Stably Infected with Bovine Leukemia Virus (BLV) Reveals Novel Apoptosis-Associated Factors

2026Open accessDamanhour University

Abstract

Bovine leukemia virus (BLV), a major cause of B-cell lymphoma in cattle worldwide, has been linked to human breast cancer. Here, we performed comparative whole-transcriptome analysis of single clones of human epithelial 293T, breast cancer MCF7, and cervical cancer HeLa cells, stably infected with BLV, versus uninfected controls using RNA-sequencing technology. Differential expression analysis revealed 2050, 1314, and 2772 differentially expressed genes (DEGs) between BLV-infected 293T, MCF7, and HeLa cells and controls, respectively. Most DEGs were upregulated in BLV-infected 293T (76.5%) and MCF7 (69.1%) cells but downregulated in HeLa cells (62.0%). Functional enrichment analyses revealed enrichment of “Gene expression” and “Membrane Trafficking” pathways across all cell lines, and that of “Apoptosis” and “Axon guidance” pathways uniquely in 293T and MCF7 cells. Twenty genes linked to apoptosis of 293T and MCF7 cells were identified, and expression of 11 of these was confirmed using quantitative real-time PCR. The expression of EFEMP1 and LXN, which showed the greatest fold change, was validated: EFEMP1 knockdown and LXN overexpression inhibited cell proliferation, induced apoptosis, and altered growth morphology of 293T and MCF7 cells. This is the first transcriptome profiling of human cells during BLV latency, which should help understand the behavior of BLV.

Research topics

  • T-cell and Retrovirus Studies
  • Animal Disease Management and Epidemiology
  • Vector-Borne Animal Diseases

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.3390/v18090934

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.